N-acetyl-l-cysteine averts ferroptosis by fostering glutathione peroxidase 4.
Cell Chem. Bio. 32, 767-775.e5 (2025)
N-acetyl-l-cysteine (NAC) is a medication and a widely used antioxidant in cell death research. Despite its somewhat obscure mechanism of action, its role in inhibiting ferroptosis is gaining increasing recognition. In this study, we demonstrate that NAC treatment rapidly replenishes the intracellular cysteine pool, reinforcing its function as a prodrug for cysteine. Interestingly, its enantiomer, N-acetyl-d-cysteine (d-NAC), which cannot be converted into cysteine, also exhibits a strong anti-ferroptotic effect. We further clarify that NAC, d-NAC, and cysteine all act as direct reducing substrates for GPX4, counteracting lipid peroxidation. Consequently, only GPX4-rather than system xc-, glutathione biosynthesis, or ferroptosis suppressor protein 1-is necessary for NAC and d-NAC to prevent ferroptosis. Additionally, we identify a broad range of reducing substrates for GPX4 in vitro, including β-mercaptoethanol. These findings provide new insights into the mechanisms underlying the protective effects of NAC and other potential GPX4-reducing substrates against ferroptosis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Fsp1 ; Gpx4 ; Gsh ; Nac ; Cysteine ; D-nac ; Ferroptosis ; System X(c)(−) ; Xct ; β-me; Separation
Keywords plus
Language
english
Publication Year
2025
Prepublished in Year
0
HGF-reported in Year
2025
ISSN (print) / ISBN
2451-9448
e-ISSN
2451-9456
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 32,
Issue: 5,
Pages: 767-775.e5
Article Number: ,
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
Cambridge, Massachusetts
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-506900-001
Grants
German Federal Ministry of Education and Research
European Research Council under the European Union
China Scholarship Council
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2025-05-11